Purespring Therapeutics
About:
Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.
Website: https://purespringtx.com/
Twitter/X: PURESPRINGTX
Top Investors: British Patient Capital, Sofinnova Partners, Forbion Capital Partners, Gilde Healthcare, Syncona Partners LLP
Description:
Purespring Therapeutics is a pioneering company focused on developing gene therapies for various kidney diseases, particularly targeting podocytes, which are specialized kidney cells. The company is among the first globally to employ AAV gene therapy specifically for kidney conditions, aiming to tackle one of the most challenging areas in medicine.
125M GBP
$1M to $10M
London, England, United Kingdom
2020-01-01
contact(AT)purespringtx.com
Mauro Giacca, Moin Saleem
11-50
2024-10-09
Private
© 2025 bioDAO.ai